| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENDP | Endo International plc | Hall Susan | EVP, CSO, Global Head of R&D | Mar 11, 2016 | Option Exercise | $41.67 | 626 | 26,085 | 4,826 | Mar 14, 2016, 05:53 PM | |
| ENDP | Endo International plc | Hall Susan | EVP, CSO, Global Head of R&D | Feb 24, 2016 | Option Exercise | $49.85 | 239 | 11,914 | 3,160 | Feb 25, 2016, 08:17 PM | |
| ENDP | Endo International plc | Hall Susan | EVP, CSO, Global Head of R&D | Nov 11, 2015 | Buy | $55.35 | 1,000 | 55,350 | 2,666 | Nov 12, 2015, 07:36 AM | |
| ENDP | Endo International plc | Hall Susan | EVP, CSO, Global Head of R&D | Mar 11, 2015 | Option Exercise | $89.44 | 626 | 55,989 | 1,666 | Mar 13, 2015, 06:16 PM | |
| VRX | Valeant Pharmaceuticals International, Inc. | Hall Susan | Global Head of R&D | Mar 07, 2012 | Sale | $33.87 | 32,240 | 1,091,941 | 16,120 | Mar 08, 2012, 07:15 PM |
Menu